Marizyme Statistics
Marizyme (MRZM) Stock Statistics & Valuation Metrics
Total Valuation
Marizyme has a market cap or net worth of $132.00. The enterprise value is $20.65T.
- Market Cap
- $132.00
- Enterprise Value
- $20.65T
Share Statistics
Marizyme has 131,793,090 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 131,793,090
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Marizyme’s return on equity (ROE) is 14.92 and return on invested capital (ROIC) is -175.14%.
- Return on Equity (ROE)
- 14.92
- Return on Assets (ROA)
- -3.16
- Return on Invested Capital (ROIC)
- -175.14%
- Return on Capital Employed (ROCE)
- 54.31
- Revenue Per Employee
- 49.68K
- Profits Per Employee
- -5.35M
- Employee Count
- 13
- Asset Turnover
- 0.03
- Inventory Turnover
- 16.37
Valuation Ratios
The current PE Ratio of Marizyme is -0.00. Marizyme’s PEG ratio is -0.00.
- PE Ratio
- -0.00
- PS Ratio
- 0.06
- PB Ratio
- -0.00
- Price to FCF
- -0.01
- Price to Operating Cash Flow
- -0.00
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Marizyme had revenue of 645.81K and earned -69.54M in profits. Earnings per share was -1.53.
- Revenue
- 645.81K
- Gross Profit
- 238.91K
- Operating Income
- -34.09M
- Pretax Income
- -65.35M
- Net Income
- -69.54M
- EBITDA
- -55.44M
- Earnings Per Share (EPS)
- -1.53
Cash Flow
In the last 12 months, operating cash flow was -3.84M and capital expenditures 4, giving a free cash flow of -3.84M billion.
- Operating Cash Flow
- -3.84M
- Free Cash Flow
- -3.84M
- Free Cash Flow per Share
- -0.10
Dividends & Yields
Marizyme pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -11848.94%
- Earnings Yield
- -509746.04%
Stock Price Statistics
- Beta
- 13.56
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.04
- 200-Day Moving Average
- 0.04
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
Marizyme as a current ratio of 0.04, with Debt / Equity ratio of -445.38%
- Current Ratio
- 0.04
- Quick Ratio
- 0.04
- Debt to Market Cap
- 4.32
- Net Debt to EBITDA
- -0.37
- Interest Coverage Ratio
- -1.13
Taxes
In the past 12 months, Marizyme has paid 4.19M in taxes.
- Income Tax
- 4.19M
- Effective Tax Rate
- -0.06
Enterprise Valuation
Marizyme EV to EBITDA ratio is -0.37, with an EV/FCF ratio of -4.41.
- EV to Sales
- 31.97
- EV to EBITDA
- -0.37
- EV to Free Cash Flow
- -4.41
- EV to Operating Cash Flow
- -4.41
Balance Sheet
Marizyme has $63.73K in cash and marketable securities with $26.66M in debt, giving a net cash position of -$26.59M billion.
- Cash & Marketable Securities
- $63.73K
- Total Debt
- $26.66M
- Net Cash
- -$26.59M
- Net Cash Per Share
- -$0.20
- Tangible Book Value Per Share
- -$0.27
Margins
Gross margin is 36.99%, with operating margin of -5278.10%, and net profit margin of -10767.77%.
- Gross Margin
- 36.99%
- Operating Margin
- -5278.10%
- Pretax Margin
- -10118.60%
- Net Profit Margin
- -10767.77%
- EBITDA Margin
- -8585.15%
- EBIT Margin
- -8715.41%
Analyst Forecast
The average price target for Marizyme is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
